Avantor, Inc. (AVTR)

14.7 0.13 (0.89%)

As of 2025-10-16 17:55:19 EST

Avantor, Inc. is an American biotechnology, chemicals, and pharmaceutical company headquartered in Radnor, Pennsylvania. Established in 1904 as J.T. Baker, the company changed its name to Avantor in 2010. Avantor went public in 2019 and is now listed on the New York Stock Exchange under the symbol “AVTR”.

Traded asNYSE: AVTR
ISINUS05352A1007
CIK0001722482
LEI
EIN822758923
SectorPharmaceuticals
IndustryLaboratory Analytical Instruments
CEOEmmanuel Ligner
Employees14,500
Fiscal Year End1231
AddressRADNOR CORPORATE CENTER, BUILDING ONE, RADNOR, PA, 19087
Phone(610) 386-1700
Websitehttp://avantorsciences.com
Stock Quotes
trading_symbolregistrant_nametimepricechangepercentage_change
AVTRAvantor, Inc.2025-10-16 17:55:1914.70.130.89
This is a preview of the latest data. Subscribe to access the full data.
Company Information
trading_symbolcentral_index_keyregistrant_nameisin_numberlei_numberein_numberexchangesic_codesic_descriptionfiscal_year_endstate_of_incorporationaddress_streetaddress_cityaddress_stateaddress_zip_codeaddress_countryaddress_country_codephone_numbermailing_addressbusiness_addressformer_nameindustryfounding_datechief_executive_officernumber_of_employeeswebsitemarket_capshares_issuedshares_outstandingdescriptionupdate_time
AVTR0001722482Avantor, Inc.US05352A1007822758923NYSE3826Laboratory Analytical Instruments1231RADNOR CORPORATE CENTER, BUILDING ONERADNORPA19087UNITED STATESUS(610) 386-1700RADNOR CORPORATE CENTER, BUILDING ONE, RADNOR, PA, 19087RADNOR CORPORATE CENTER, BUILDING ONE, RADNOR, PA, 19087Vail Holdco CorpPharmaceuticals1904Emmanuel Ligner14,500http://avantorsciences.com13,877,913,401681,600,000681,738,675Avantor, Inc. is an American biotechnology, chemicals, and pharmaceutical company headquartered in Radnor, Pennsylvania. Established in 1904 as J.T. Baker, the company changed its name to Avantor in 2010. Avantor went public in 2019 and is now listed on the New York Stock Exchange under the symbol “AVTR”.2025-10-10 19:55:09
This is a preview of the latest data. Subscribe to access the full data.
AVTR Stock Price (End-of-Day)
This is a preview of the latest data. Subscribe to access the full data.
AVTR Stock Price (1-Minute)
This is a preview of the latest data. Subscribe to access the full data.
Market Cap
Fiscal YearMarket CapChange In Market CapPercentage Change In Market CapShares OutstandingChange In Shares OutstandingPercentage Change In Shares Outstanding
202414,407,779,658529,866,2573.8181680,902,5722,621,1890.3864
202313,877,913,401-7,081,445,257-33.7866678,281,3833,837,8770.569
202220,959,358,658229,229,0511.1058674,443,50664,475,41010.5703
This is a preview of the latest data. Subscribe to access the full data.
Executive Compensation
Executive NameExecutive PositionFiscal YearSalaryBonusStock AwardsIncentive Plan CompensationOther CompensationTotal Compensation
Randy StoneExecutive Vice President2023415,38502,105,34234,19233,2004,588,116
Frederic VanderhaegenExecutive Vice President2023618,21201,749,55952,761122,8953,043,353
Michael StubblefieldChief Executive Officer, Director, President20231,140,00008,529,219188,10036,50012,338,767
R. Brent JonesChief Financial Officer, Executive Vice President2023221,154200,0002,817,99818,52622,0155,840,795
James BramwellExecutive Vice President2023497,98101,749,55939,38433,6502,840,235
This is a preview of the latest data. Subscribe to access the full data.
Employee Count
Fiscal YearEmployee Count
202413,500
202314,500
202214,500
This is a preview of the latest data. Subscribe to access the full data.
Income Statements
Fiscal Year202420232022
Revenue6,783,600,0006,967,200,0007,512,400,000
Cost Of Revenue4,504,300,0004,603,400,0004,909,600,000
Gross Profit2,279,300,0002,363,800,0002,602,800,000
Research And Development Expenses
General And Administrative Expenses1,641,100,0001,506,600,0001,472,600,000
Operating Expenses
Operating Income1,084,800,000696,400,0001,130,200,000
Net Income711,500,000321,100,000686,500,000
Earnings Per Share Basic1.050.481.02
Earnings Per Share Diluted1.040.471.01
Weighted Average Shares Outstanding Basic679,600,000675,600,000650,900,000
Weighted Average Shares Outstanding Diluted681,900,000678,400,000679,400,000
This is a preview of the latest data. Subscribe to access the full data.
Balance Sheet Statements
Fiscal Year202420232022
Cash And Cash Equivalents261,900,000262,900,000372,900,000
Marketable Securities Current
Accounts Receivable1,034,500,0001,150,200,0001,218,400,000
Inventories731,500,000828,100,000913,500,000
Non Trade Receivables
Other Assets Current118,700,000143,700,000153,100,000
Total Assets Current2,146,600,0002,384,900,0002,657,900,000
Marketable Securities Non Current
Property Plant And Equipment708,100,000737,500,000727,000,000
Other Assets Non Current360,400,000358,300,000293,500,000
Total Assets Non Current9,967,900,00010,587,800,00010,806,400,000
Total Assets12,114,500,00012,972,700,00013,464,300,000
Accounts Payable662,800,000625,900,000758,200,000
Deferred Revenue
Short Term Debt821,100,000259,900,000364,200,000
Other Liabilities Current306,800,000411,200,000364,100,000
Total Liabilities Current2,007,500,0001,480,300,0001,658,800,000
Long Term Debt4,055,800,0005,536,600,0006,287,500,000
Other Liabilities Non Current358,300,000350,300,000295,400,000
Total Liabilities Non Current4,150,300,0006,239,800,0006,950,100,000
Total Liabilities6,157,800,0007,720,100,0008,608,900,000
Common Stock3,937,700,0003,830,100,0003,785,300,000
Retained Earnings2,203,000,0001,491,500,0001,170,400,000
Accumulated Other Comprehensive Income-184,000,000-69,000,000-100,300,000
Total Shareholders Equity5,956,700,0005,252,600,0004,855,400,000
This is a preview of the latest data. Subscribe to access the full data.
Cash Flow Statements
Fiscal Year202420232022
Depreciation And Amortization299,800,000402,300,000405,500,000
Share Based Compensation Expense46,800,00040,500,00045,800,000
Other Non Cash Income Expense300,000700,0007,000,000
Change In Accounts Receivable-45,900,000-77,000,00045,200,000
Change In Inventories18,500,000-30,300,000112,500,000
Change In Non Trade Receivables
Change In Other Assets
Change In Accounts Payable59,600,000-139,600,00015,600,000
Change In Other Liabilities37,700,000-48,600,000179,300,000
Cash From Operating Activities840,800,000870,000,000843,600,000
Purchases Of Marketable Securities
Sales Of Marketable Securities
Acquisition Of Property Plant And Equipment148,800,000146,400,000133,400,000
Acquisition Of Business0020,200,000
Other Investing Activities-2,500,000-2,700,000-1,500,000
Cash From Investing Activities438,900,000-143,700,000-109,600,000
Tax Withholding For Share Based Compensation
Payments Of Dividends
Issuance Of Common Stock00
Repurchase Of Common Stock
Issuance Of Long Term Debt00327,200,000
Repayment Of Long Term Debt1,341,800,000846,000,000947,000,000
Other Financing Activities-8,600,000-13,700,000-13,200,000
Cash From Financing Activities-1,281,200,000-843,700,000-648,700,000
Change In Cash-23,000,000-109,200,00069,800,000
Cash At End Of Period261,900,000262,900,000372,900,000
Income Taxes Paid247,800,000224,400,000256,900,000
Interest Paid211,000,000267,000,000242,200,000
This is a preview of the latest data. Subscribe to access the full data.
Key Metrics
Fiscal Year202420232022
Earnings Per Share1.050.481.02
Price To Earnings Ratio20.066747.562520.6765
Earnings Growth Rate118.75-52.941218.6047
Price Earnings To Growth Ratio0.169-0.89841.1114
Book Value Per Share8.7657.77477.4595
Price To Book Ratio2.40392.93642.8273
Ebitda1,477,900,0001,232,600,0001,614,700,000
Enterprise Value18,934,172,00020,957,548,00020,006,281,000
Dividend Yield
Dividend Payout Ratio
Debt To Equity Ratio0.81871.10351.37
Capital Expenditures270,400,000412,800,000427,000,000
Free Cash Flow570,400,000457,200,000416,600,000
Return On Equity0.11940.06110.1414
One Year Beta0.80670.83760.9891
Three Year Beta0.9290.96951.0906
Five Year Beta1.04911.06581.0867
This is a preview of the latest data. Subscribe to access the full data.
Insider Transactions
Insider NameRelationship To IssuerTransaction DateAmount Of SecuritiesAcquired Or DisposedSecurities Owned Following Transaction
LUCIER GREGORY TDirector2025-10-038,736A8,736
Gourdier BenoitEVP, Bioscience Production2025-10-021,264D235,684
SUMME GREGORY LDirector2025-08-21100,000A200,000
Ligner EmmanuelDirector, President and CEO2025-08-18195,924A195,924
Ligner EmmanuelDirector, President and CEO2025-08-18573,394A573,394
This is a preview of the latest data. Subscribe to access the full data.
House Trading
Name Of Reporting PersonReport DateStateTransaction TypeTransaction DateOwner TypeAmount
Gilbert Cisneros2025-09-12CA31Sale2025-08-13$1,001 - $15,000
Gilbert Cisneros2025-09-12CA31Sale (Partial)2025-08-12$1,001 - $15,000
Gilbert Cisneros2025-08-14CA31Sale (Partial)2025-07-23$1,001 - $15,000
Lisa McClain2025-08-13MI09Purchase2025-06-11Spouse$1,001 - $15,000
Lisa McClain2025-08-13MI09Sale (Partial)2025-06-17Spouse$1,001 - $15,000
This is a preview of the latest data. Subscribe to access the full data.
Institutional Holdings
Investor NamePeriod Of ReportMarket ValueAmount Of SecuritiesPrice Per Security
Blue Trust, Inc.2025-09-30314,75825,22112.48
CWM, LLC2025-09-3037,0002,93512.6065
Pacer Advisors, Inc.2025-09-301,119,70689,72012.48
PRIVATE TRUST CO NA2025-09-3023,6371,89412.4799
Vontobel Holding Ltd.2025-09-301,070,17385,75112.48
This is a preview of the latest data. Subscribe to access the full data.
Mutual Fund Holdings
Registrant NamePeriod Of ReportFund NameFund SymbolAmount Of UnitsValue In UsdPercentage Value Compared To Assets
TRUST FOR PROFESSIONAL MANAGERS2025-08-31Column Small Cap FundCFSLX18,425248,184.750.0518
Pacer Funds Trust2025-07-31Pacer Trendpilot US Mid Cap ETFPTMC96,6241,298,626.560.3099
Dimensional ETF Trust2025-07-31Dimensional U.S. Core Equity 2 ETFDFAC12,658170,123.520.0005
Dimensional ETF Trust2025-07-31Dimensional U.S. Targeted Value ETFDFAT1,226,24716,480,759.680.1528
FLEXSHARES TRUST2025-07-31FlexShares Morningstar US Market Factor Tilt Index FundTILT117,6291,580,933.760.0916
This is a preview of the latest data. Subscribe to access the full data.